Trial Outcomes & Findings for Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain (NCT NCT01614925)
NCT ID: NCT01614925
Last Updated: 2020-12-01
Results Overview
The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.
TERMINATED
35 participants
12 Months
2020-12-01
Participant Flow
The recruitment was terminated prematurely.
Participant milestones
| Measure |
Emdogain
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Overall Study
STARTED
|
18
|
17
|
|
Overall Study
COMPLETED
|
14
|
15
|
|
Overall Study
NOT COMPLETED
|
4
|
2
|
Reasons for withdrawal
| Measure |
Emdogain
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
1
|
0
|
|
Overall Study
Protocol Violation
|
3
|
2
|
Baseline Characteristics
Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain
Baseline characteristics by cohort
| Measure |
Emdogain
n=18 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=17 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
Total
n=35 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
50.3 years
STANDARD_DEVIATION 14.0 • n=5 Participants
|
53.9 years
STANDARD_DEVIATION 13.2 • n=7 Participants
|
52.4 years
STANDARD_DEVIATION 13.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
8 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
5 participants
n=5 Participants
|
7 participants
n=7 Participants
|
12 participants
n=5 Participants
|
|
Region of Enrollment
Switzerland
|
3 participants
n=5 Participants
|
3 participants
n=7 Participants
|
6 participants
n=5 Participants
|
|
Region of Enrollment
Germany
|
10 participants
n=5 Participants
|
7 participants
n=7 Participants
|
17 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 MonthsThe change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Clinical Attachment Level
|
-2.91 mm
Standard Deviation 1.3
|
-2.08 mm
Standard Deviation 1.32
|
SECONDARY outcome
Timeframe: 12 months after baselineGM was measured by recording the distance from the Cemento-Enamel Junction (CEJ) to the margin of the gingiva at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesio-oral, mid-oral, disto-oral) on the study teeth. Negative value for GM indicates gingival recession. A positive value for the GM indicates the gingiva was covering the CEJ.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Change in Gingival Margin (GM) From Baseline to 12 Months
|
-0.36 mm
Standard Deviation 0.84
|
-0.27 mm
Standard Deviation 1.53
|
SECONDARY outcome
Timeframe: 12 months after baselinePPD was measured before the area is anaesthetized by recording the distance from the gingival margin to the bottom of the probable pocket at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesiooral, mid-oral, and disto-oral) on the study teeth.Negative value for PPD indicates reduction of pocket depth.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Change in Probing Pocket Depth (PPD) From Baseline to 12 Months
|
-2.93 mm
Standard Deviation 1.44
|
-2.47 mm
Standard Deviation 1.12
|
SECONDARY outcome
Timeframe: 4 weeks after baselinePostoperative wound healing was assessed by the EHI according to Wachtel et al. \[2003\] by visual assessment: 1. complete flap closure - no fibrin line in the interproximal area 2. complete flap closure - fine fibrin line in the interproximal area 3. complete flap closure - fibrin clot in the interproximal area 4. incomplete flap closure - partial necrosis of the interproximal tissue 5. incomplete flap closure - complete necrosis of the interproximal tissue The outcome measure was the percentage of EHI category 1 (complete flap closure - no fibrin line in the interproximal area)
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Early Wound Healing Index (EHI) Assessment at 4 Weeks After Baseline
|
93 percentage of EHI category 1
|
100 percentage of EHI category 1
|
SECONDARY outcome
Timeframe: 4 weeks after baselineVisual Analog Scale (VAS) for post-surgical pain, minimum value=0, maximum value=10, higher score means worse outcome
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Comparison of Post-surgical Pain at 4 Weeks After Baseline
|
3.21 score on a scale
Standard Deviation 9.39
|
3.47 score on a scale
Standard Deviation 7.77
|
SECONDARY outcome
Timeframe: 12 months after baselineThe presence of BoP was recorded as a binary response on 6 sites (mesio-vestibular, midvestibular, disto-vestibular, mesio-oral, mid-oral, and disto-oral) on the study teeth. The percentage of positive events per total probing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in BoP.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Change in Bleeding on Probing (BoP) From Baseline to 12 Months
|
-36 percentage of BoP change
|
-13 percentage of BoP change
|
SECONDARY outcome
Timeframe: 12 months after baselineRDH was examined by physical testing using cold air as a stimulus. The percentage of positive events per total testing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in RDH.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Change in Root Dentin Hypersensitivity (RDH) From Baseline to 12 Months
|
-21.4 percentage of RDH change
|
-26.7 percentage of RDH change
|
SECONDARY outcome
Timeframe: 12 months after baselineThe PI was recorded according to O'Leary et al. \[1972\] as a binary response at the mesial, distal, facial and lingual surfaces on the study teeth. The percentage of positive events per total sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in PI.
Outcome measures
| Measure |
Emdogain
n=14 Participants
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=15 Participants
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
Change in Plaque Index (PI) From Baseline to 12 Months
|
14.7 percentage of PI change
|
13.4 percentage of PI change
|
Adverse Events
Emdogain
Periodontal Surgery
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Emdogain
n=18 participants at risk
Periodontal surgery with the additional use of Straumann® Emdogain
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain
|
Periodontal Surgery
n=17 participants at risk
Periodontal surgery alone
Periodontal surgery: Periodontal surgery alone
|
|---|---|---|
|
General disorders
Tooth hypersensitivity
|
0.00%
0/18 • 1 year
|
5.9%
1/17 • Number of events 1 • 1 year
|
|
General disorders
Aphthous ulcer
|
5.6%
1/18 • Number of events 1 • 1 year
|
0.00%
0/17 • 1 year
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place